Our Publications
Show: AllPeer ReviewedNon Peer Reviewed
24 publications from 2020
Yakoub-Agha I, Chabannon C, Bader P, Basak GW, Bonig H, Ciceri F, Corbacioglu S, Duarte RF, Einsele H, Hudecek M, Kersten MJ, Köhl U, Kuball J, Mielke S, Mohty M, Murray J, Nagler A, Robinson S, Saccardi R, Sanchez-Guijo F, Snowden JA, Srour M, Styczynski J, Urbano-Ispizua A, Hayden PJ, Kröger N., Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)., Haematologica, 105, (2), 2020, p297-316
Morris C, Chabannon C, Masszi T, Russell N, Nahi H, Kobbe G, Krejci M, Auner HW, Pohlreich D, Hayden P, Basak GW, Lenhoff S, Schaap N, van Biezen A, Knol C, Iacobelli S, Liu Q, Celanovic M, Garderet L, Kröger N., Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor., Bone marrow transplantation, 55, (2), 2020, p356-366
Hayden PJ, Iacobelli S, Pérez-Simón JA, van Biezen A, Minnema M, Niittyvuopio R, Schönland S, Meijer E, Blaise D, Milpied N, Márquez-Malaver FJ, Veelken JH, Maertens J, Michallet M, Cammenga J, N'Guyen S, Niederwieser D, Hunault-Berger M, Bourhis JH, Passweg J, Bermudez A, Chalandon Y, Yakoub-Agha I, Garderet L, Kröger N., Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP., European journal of haematology, 104, (3), 2020, p181-189
McLornan DP, Malpassuti V, Lippinkhof-Kozijn A, Potter V, Beelen D, Bunjes D, Sengeloev H, Radujkovic A, Passweg J, Chalandon Y, Kröger N, Wulf GG, Johansson JE, Ciceri F, Bornhäuser M, Holler E, Guffroy B, Martin S, Neubauer A, Gramatski M, Robin M, Iacobelli S, Hayden P, Hernández Boluda JC, Czerw T, Yakoub-Agha I., Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT., British journal of haematology, 190, (3), 2020, p437-441
Weisel K, Dimopoulos M, Moreau P, Yagci M, Larocca A, Kanate AS, Vural F, Cascavilla N, Basu S, Johnson P, Byeff P, Hus M, Rodríguez-Otero P, Muelduer E, Anttila P, Hayden PJ, Krauth MT, Lucio P, Ben-Yehuda D, Mendeleeva L, Guo S, Yu X, Grote L, Biyukov T, Dhanasiri S, Richardson P., Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma., Leukemia & lymphoma, 61, (8), 2020, p1850-1859
Beauvais D, Danhof S, Hayden PJ, Einsele H, Yakoub-Agha I., Clinical data, limitations and perspectives on chimeric antigen receptor T-cell therapy in multiple myeloma., Current opinion in oncology, 32, (5), 2020, p418-426
Garderet L, Morris C, Beksac M, Gahrton G, Schönland S, Yakoub-Agha I, Hayden PJ., Are Autologous Stem Cell Transplants Still Required to Treat Myeloma in the Era of Novel Therapies? A Review from the Chronic Malignancies Working Party of the EBMT., Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 26, (9), 2020, p1559-1566
Sellner L, Schetelig J, Koster L, Choi G, Blaise D, Beelen D, Schianca FC, Passweg J, Schanz U, Gyan E, Sora F, Kröger N, Wulf GG, Van Gorkom G, Mayer J, Orvain C, Bourhis JH, Jindra P, Potter V, Zallio F, Vandenberghe E, Robinson S, Hayden PJ, Yakoub-Agha I, Montoto S, Dreger P, on behalf of the European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties., Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey., Bone marrow transplantation, 55, (12), 2020, p2335-2338
Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M., Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia., Frontiers in immunology, 11, 2020, p584520
Viola Previtali , Helene B Mihigo , Rebecca Amet, Anthony M McElligott , Daniela M Zisterer , Isabel Rozas , Exploring the Anti-Cancer Mechanism of Novel 3,4'-Substituted Diaryl Guanidinium Derivatives, Pharmaceuticals (Basel), 13, (12), 2020, p485
Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin‐Loeches, Paul Browne, Christopher L Bacon, Richard Gaule, Alexander Gillett, Mary Byrne, Kevin Ryan, Niamh O'Connell, Jamie M O'Sullivan, Niall Conlon, James S O'Donnell, COVID 19 coagulopathy in caucasian patients, British Journal of Haematology, 89, (6), 2020, p1044 - 1049
, The Irish Experience of Thiotepa, Carmustine and Etoposide Conditioning Prior to ASCT for the Treatment of Central Nervous System Lymphomas, BONE MARROW TRANSPLANTATION, 2020
, Real-world experience of BRAF V600E mutation testing in hairy cell leukaemia, Journal of clinical pathology, 2020
, Philadelphia chromosome-positive acute lymphoblastic leukemia with an e14a3 BCR-ABL1 fusion: The role of molecular monitoring, Hematology/oncology and stem cell therapy, 2020
, A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination with Tremelimumab or Danvatirsen in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Clinical Lymphoma Myeloma and Leukemia, 2020
Orfali N., O'Donovan T.R., Cahill M.R., Benjamin D., Nanus D.M., McKenna S.L., Gudas L.J., Mongan N.P., All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL), European Journal of Haematology, 104, (3), 2020, p236 - 250, p236-250
Orfali N., Shan-Krauer D., O'Donovan T.R., Mongan N.P., Gudas L.J., Cahill M.R., Tschan M.P., McKenna S.L., Inhibition of UBE2L6 attenuates ISGylation and impedes ATRA-induced differentiation of leukemic cells, Molecular Oncology, 14, (6), 2020, p1297 - 1309, p1297-1309
Orfali N., van Besien K., Combining haplo-identical and cord blood stem cell grafts"might the whole be greater than the sum of its parts?, Leukemia and Lymphoma, 61, (4), 2020, p753 - 756, p753-756
Van Besien K.W., Orfali N., Alternative donor transplantation for lymphoid malignancies: How far we have come, Journal of Clinical Oncology, 38, (14), 2020, p1501 - 1504, p1501-1504
Salvatore M., Laplante J.M., Soave R., Orfali N., Plate M., van Besien K., St. George K., Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir, Transplant Infectious Disease, 22, (4), 2020
Gomez-Arteaga A., Orfali N., Guarneri D., Cushing M.M., Gergis U., Hsu J., Hsu Y.-M.S., Mayer S.A., Phillips A.A., Chase S.A., Mokhtar A.E., Shore T.B., Van Besien K., Cord blood transplants supported by unrelated donor CD34+ progenitor cells, Bone Marrow Transplantation, 55, (12), 2020, p2298 - 2307, p2298-2307
Chaekal O.-K., Scaradavou A., Frenet E.M., Albano M.S., Cushing M., Desai P., Dobrila L., Gergis U., Guarneri D., Hsu J.-M., Lee S., Mayer S.A., Phillips A.A., Orfali N., Ritchie E.K., Roboz G.J., Romeo C., Samuel M.S., Shore T., van Besien K., Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response, Blood Advances, 4, (20), 2020, p5146 - 5156, p5146-5156
Van Besien K., Orfali N., Shore T., Allogeneic Transplant Conditioning Regimens for Patients with Non-Hodgkin Lymphoma, JAMA Oncology, 6, (12), 2020, p1980-
Ta R, Santini C, Gou P, Lee G, Tai YC, O'Brien C, Fontecha M, Grant C, Bacon L, Finn S, Vandenberghe E, Quinn F, Dua R, Flavin R., Molecular Subtyping of Diffuse Large B-Cell Lymphoma Using a Novel Quantitative RT-PCR Assay , J Mol Diagn, 2020, pS1525-1578-